文献速递免疫规划传染病防控与疫情报告

加拿大1992-2012年免疫接种后儿童脑炎/脑病病例的主动监测回顾

Review of pediatric encephalitis and encephalopathy cases following immunization reported to the Canadian Immunization Monitoring Program Active (IMPACT) from 1992 to 2012.
PubMed 文献 · Vaccine · 2020-05-12

该研究描述了1992至2012年通过加拿大免疫监测项目主动监测系统报告的免疫接种后儿童脑病/脑炎病例。多数病例存在更可能的其他病因,未发现与百日咳或流感疫苗存在因果关联。

要点

  • 免疫接种后脑病/脑炎罕见但严重,多数病例有其他更可能的病因。
  • 急性病例定义接种后症状出现时间窗因疫苗类型而异。
  • 未发现百日咳或流感疫苗与脑炎存在因果关联。

核心结论

  • 免疫接种后脑病/脑炎仍是罕见但严重的不良事件,多数病例有其他更可能的病因而非疫苗。
  • 未发现脑炎与百日咳或流感疫苗存在因果关联。
  • 持续监测和分析免疫接种后不良事件对确保免疫规划安全至关重要。

研究设计与样本

  • 基于加拿大免疫监测项目主动监测系统的病例系列描述性分析。
  • 急性病例报告条件为症状出现在含破伤风或百日咳疫苗后0-7天、其他灭活疫苗后0-15天或活疫苗后5-30天。
  • 慢性病例为亚急性硬化性全脑炎或亚急性进行性风疹脑炎,报告间隔不限。

主要发现

  • 73.8%的患者既往健康且免疫功能正常。
  • 发病前最常接种的疫苗为百白破、麻腮风和流感疫苗。
  • 出院时38例(62.3%)神经系统状态正常或预期恢复。

临床怎么用

  • 临床遇免疫接种后脑病/脑炎病例应系统排查其他病因,尤其是感染。
  • 应结合接种疫苗类型和症状出现时间窗判断病例是否需报告至主动监测系统。
  • 持续开展免疫接种后不良事件主动监测有助于评估疫苗安全性。

局限性

  • 原文未明确报告本研究的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neurological adverse events following immunization (AEFI) remain poorly characterized. Our objective was to describe pediatric acute and chronic encephalopathy and encephalitis cases following immunization reported via active sentinel surveillance from 1992 to 2012. METHODS: This case series provides a descriptive analysis of encephalopathy/encephalitis admissions reported to the Canadian Immunization Monitoring Program ACTive (IMPACT). Acute cases were reported if symptom onset (seizures, decreased level of consciousness, change in mental status) occurred 0-7 days after tetanus or pertussis-containing vaccines, 0-15 days after other inactivated vaccines, or 5-30 days after live vaccines. Chronic cases of subacute sclerosing panencephalitis or subacute progressive rubella encephalitis were reported at any interval after vaccination. Clinical data were examined to identify possible causes for encephalopathy/encephalitis other than vaccination. RESULTS: Sixty-one cases of encephalopathy/encephalitis following immunization were reported to IMPACT over 21 years; 57 (93.4%) were classified as acute and 4 (6.6%) were chronic cases of subacute sclerosing panencephalitis. Most patients (73.8%) were previously healthy and immunocompetent. The vaccines most frequently administered prior to presentation were diphtheria-tetanus-pertussis, measles-mumps-rubella, and influenza. At discharge, 38 patients (62.3%) had normal neurological status or were expected to recover. Forty patients (70.2%) with acute encephalopathy/encephalitis had a more likely alternate etiology besides vaccination based on neuroimaging, symptoms suggestive of infection, laboratory-confirmed non-vaccine-related infection, or clinical diagnosis. No cases of encephalitis were causally associated with pertussis or influenza vaccines. Two patients (50%) with subacute sclerosing panencephalitis had known wild-type measles infection prior to immunization. Three deaths were reported during hospitalization (4.9%); all were acute encephalitis/encephalopathy cases and none were confirmed to be vaccine-related. CONCLUSIONS: Encephalopathy/encephalitis following immunization remains a rare but serious adverse event. Most cases had another more likely etiology than vaccination. Continued monitoring and analysis of AEFI is paramount to ensure the safety of immunization programs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tam J, Tran D, Bettinger JA, et al. Review of pediatric encephalitis and encephalopathy cases following immunization reported to the Canadian Immunization Monitoring Program Active (IMPACT) from 1992 to 2012. Vaccine. 2020. PMID: 32414652. doi:10.1016/j.vaccine.2020.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。